I. COMMENCED TRADING IN NOVEMBER
INITIAL OFFERINGS
There were no initial public offerings in November.
FOLLOW-ON OFFERINGS
There were no follow-on offerings in November.
II. FILED AND PENDING
Company Date Shares/ Price Shares Lead, Value@
(Symbol) Filed Units (M) Range Out (M) Other UWs ($M)
INITIAL OFFERINGS
Anthra Pharmaceuticals Inc.* 3/11; 11/16 2.0U $5 6.9 JM $10
Praecis Pharmaceuticals Inc. 8/12 3.5S $14-$16 19.2 BTAB; NBMS $49
NOTE:
* Anthra Pharmaceuticals Inc. has amended its initial public offering prospectus several times, most recently on 11/16/98. Each unit consists of 1 share of stock and 1 5-year warrant to buy 1 share of stock at $6.00. The company is now planning to list its units, common stock and warrants on the Nasdaq SmallCap Market; previously, it had planned to list the securities on the American Stock Exchange.
FOLLOW-ON OFFERINGS
Anesta Corp. 11/20 1.8S 11.4 BRS, VBW $38.4
(NSTA)*
NOTE:
* Anesta Corp. registered 2M shares in its follow-on offering; the company is offering 1.8M shares and selling stockholders are offering 0.2M shares.
III. WITHDRAWN OR POSTPONED
Company Date Shares/ Price Shares Lead, Value@
(Symbol) Filed Units (M) Range Out (M) Other UWs ($M)
Lifecodes Corp.* 7/17; 9/3 2.9S $10-$12 6.6 VBW; VSI; AI $29
NOTE:
* Lifecodes Corp. withdrew its initial public offering prospectus 12/1/98. The company did not state a reason.
OTHER NOTES:
E = estimated; ND = not disclosed, reported and/or available; S = shares; U = units; W = warrants
"Date filed" indicates the date on which the company announced that it had filed a preliminary prospectus with the Securities and Exchange Commission for its offering. It is not necessarily the same date as that which is printed on the preliminary prospectus itself.
In completed offerings, the number of shares sold includes the overallotment (in full or in part) if that option has been exercised by the time this publication goes to press.
Shares outstanding refers to the number of shares outstanding after the public offering. In the case of those offerings which are still pending, it assumes that the number of shares sold in the offering will be equal to the number intended for sale as per the prospectus.
@ Values are estimated from the low-end range for initial public offerings and the 12/2/98 closing price for follow-on offerings.

Underwriters' Key:

AI (Advest Inc.); BRS (BancBoston Robertson Stephens); BTAB (BT Alex. Brown Inc.); JM (Janssen/Meyers Associates LP); NBMS (NationsBanc Montgomery Securities Inc.); VBW (Volpe Brown Whelan & Co.); VSI (Vector Securities International Inc.)

No Comments